Shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Free Report) shot up 79.6% during mid-day trading on Tuesday . The company traded as high as $0.2707 and last traded at $0.2707. 666 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 3,753 shares. The stock had previously closed at $0.1507.
Ampio Pharmaceuticals Stock Up 79.6%
The firm’s 50 day moving average is $0.11 and its 200 day moving average is $0.05. The firm has a market capitalization of $307,244.50, a price-to-earnings ratio of -0.02 and a beta of 6.34.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc is a clinical‐stage biopharmaceutical company focused on developing therapies that modulate the body’s inflammatory response to alleviate pain and improve functional outcomes. Headquartered in Englewood, Colorado, the company leverages proprietary plasma‐derived and synthetic formulations to target chronic musculoskeletal and cardiovascular conditions.
The company’s lead product candidate, Ampion, is a novel, low‐molecular‐weight fraction of human serum albumin designed as a single intra‐articular injection for patients suffering from osteoarthritis of the knee.
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
